JSE suspends another company over late financial statements

Medical Disposables & Supplies Limited has become the fifth company suspended by the Jamaica Stock Exchange in 2026 for failing to submit its audited financial statements on time.

The suspension took effect on September 1 and will remain in place until MDS files its audited financial statements for March 2026. The statements were due on May 30. Under JSE rules, companies receive a 90-day grace period for late financial submissions before trading in their securities is halted.

MDS said an unforeseen IT incident disclosed in May disrupted its accounting records. “The restoration and independent validation of the affected historical financial records have proven to be taking more time than originally anticipated,” the company said in a market update. It did not explain the nature of the incident. The delay has also held up the company’s first-quarter report for the period ending June 30.

“

The restoration and independent validation of the affected historical financial records have proven to be taking more time than originally anticipated.

MDS expects its audited financial statements to be ready by the end of November 2026, six months after the original deadline. Trading will therefore remain suspended for at least two months, leaving shareholders unable to trade their shares during that period.

The company said it continues to operate normally and that there was no evidence of unauthorized access, a cyberattack, fraud, or the compromise of customer, employee, or commercially sensitive information. The JSE had also suspended Kintyre Holdings (Ja) Limited, Portland JSX Limited, Derrimon Trading Company Limited, and Atlantic Hardware & Plumbing Company Limited for overdue filings. Derrimon and Atlantic Hardware returned to trading in early July after submitting their statements. A Jamaica Observer review found that only 48 percent of reporting issuers had filed their audited financial statements on time between August.

“

MDS wishes to reassure the JSE, its shareholders and the wider market that the company continues to operate normally at the business level, that there remains no evidence of unauthorised access, cyberattack, fraud, or compromise of customer, employee, or commercially sensitive information, and that the board and management remain fully engaged in overseeing the recovery programme.